IVF Reads / Is PMS Linked to Infertility?

Is PMS Linked to Infertility?

M
Written by MayaPublished Updated
IVFPulse blog image
AI summary

PMS does not cause infertility. Premenstrual symptoms are triggered by the normal hormone fluctuations of an ovulatory cycle in women who are more sensitive to them, not by abnormal hormone levels, and they are absent in cycles without ovulation (Yonkers, O'Brien and Eriksson, Lancet 2008). Cycle symptoms deserve a fertility workup when they include disabling period pain or pain with sex (endometriosis, NICE NG73), cycles shorter than 21 or longer than 35 days (2023 international PCOS guideline), or symptoms that last all month. The combined pill and SSRIs both relieve PMS, but the pill stops ovulation and SSRIs need planning before pregnancy.

  • Yonkers et al. (Lancet 2008): PMS does not seem to be due to abnormal concentrations of sex steroids; symptoms are absent during non-ovulatory cycles and abolished by ovulation inhibitors.
  • In India, a meta-analysis of 25 studies (8,542 participants) found a pooled PMS prevalence of 43% and PMDD prevalence of 8% (Dutta and Sharma, Health Promot Perspect 2021).
  • PMDD affected 3.2% of women with a prospectively confirmed diagnosis and 7.7% on provisional diagnosis across 44 studies and 50,659 participants (Reilly et al., J Affect Disord 2024).
  • Cochrane 2024 (34 RCTs): SSRIs probably reduce premenstrual symptoms (SMD -0.57; 12 studies, 1,742 participants), more so when taken continuously than in the luteal phase only.
  • After stopping contraception, 83.1% of 14,884 women across 22 studies were pregnant within 12 months, and the duration of pill use did not change this (Girum and Wasie 2018).
  • ASRM (2021) advises infertility evaluation after 12 months of trying under age 35 and after 6 months from age 35, and without delay when cycles are irregular.

Does PMS affect fertility?

No. PMS is not a cause of infertility. The symptoms are set off by the ordinary rise and fall of oestrogen and progesterone in a cycle in which you ovulate, in women who are more sensitive to those swings; hormone levels themselves are not abnormal (Yonkers, O'Brien and Eriksson, The Lancet 2008).

That has a practical consequence. PMS symptoms disappear in cycles where no egg is released, and go away when ovulation is switched off by medication or surgery. So classic PMS is not a sign of the most common hormonal cause of female infertility, which is not ovulating. It is not proof that you ovulate either, and it says nothing about the tubes, the uterus or the sperm, which is why a couple who have been trying for a year still need a proper workup whatever their cycle feels like. Infertility affects about one in six people of reproductive age at some point in their lives (WHO 2025); PMS is not one of the causes WHO lists.

How common PMS is in India43%pooled prevalence of PMS among Indian women of reproductive age across 25 studies and 8,542 participants; PMDD, the severe form, 8%. Most of these women will conceive like anyone else; PMS is common, infertility is a separate question.Dutta and Sharma, Health Promotion Perspectives 2021;11:161-170, systematic review and meta-analysis (PMID 34195039). Heterogeneity between studies was very high.

PMS or PMDD: what is the difference?

Many women notice some breast tenderness, bloating, irritability or low mood in the week or two before a period. That becomes PMS when it is bad enough to interfere with daily life; moderate to severe symptoms have a prevalence of about 5 to 8% (Yonkers 2008; StatPearls 2026).

PMDD, premenstrual dysphoric disorder, is the severe end, and it is classed as a depressive disorder in the DSM-5. The diagnosis needs:

  • at least five of eleven listed symptoms, including at least one core mood symptom: markedly depressed mood, anxiety or tension, sudden mood swings, or persistent anger and irritability
  • symptoms in the final week before a period that ease within a few days of bleeding and are minimal in the week after
  • real impairment at work, at home or in relationships
  • confirmation by daily symptom ratings over at least two cycles, and no other condition explaining it

The charting matters. When diagnosis was confirmed with daily ratings, PMDD prevalence was 3.2%; on provisional diagnosis it was 7.7%, across 44 studies and 50,659 participants (Reilly 2024). A two-month symptom diary is often more useful than a blood test, because hormone levels in PMS and PMDD are normal.

If premenstrual low mood ever includes thoughts of harming yourself, that needs help the same day, not at the next fertility appointment. In India, Tele MANAS, the government's free mental health line, is on 14416 or 1-800-891-4416.

When do cycle symptoms point to something other than PMS?

This is the part that matters for fertility. PMS has a strict shape: symptoms after ovulation, relief soon after the period starts, and a symptom-free stretch before the next ovulation. When the pattern breaks that shape, look for another cause.

  • Pain is the main problem. Period pain that stops you functioning, deep pain during or after sex, or cyclical bowel or bladder pain are the symptoms NICE lists for suspecting endometriosis, which is often confused with PMS (NICE NG73; Yonkers 2008). See endometriosis and infertility.
  • Cycles are irregular. Cycles shorter than 21 days or longer than 35, or fewer than eight periods a year, count as irregular in the 2023 international PCOS guideline and point towards ovulation problems. ASRM advises testing without waiting the usual year. See not ovulating: causes and tests and PCOS and fertility.
  • Symptoms last all month. That is not PMS by definition. Depression, anxiety and thyroid disease should be checked first; Yonkers 2008 lists hypothyroidism among the conditions to rule out before treating PMS. See thyroid and fertility.
  • You have been trying for a while. Whatever your cycle feels like, the time limits for a fertility evaluation still apply (below).
When to get a fertility evaluation12 months / 6 monthsof trying without a pregnancy: ASRM advises evaluation at 12 months under age 35 and at 6 months from 35, sooner over 40 or with irregular cycles. NICE NG257 uses one year, with specialist referral straight away from age 36. PMS does not change these limits.ASRM Practice Committee, Fertility evaluation of infertile women: a committee opinion, 2021; NICE NG257 (2026) recommendations 1.16.5 and 1.16.8.

Treating PMS while trying to conceive

The treatments that work best for PMS act on the cycle or on brain chemistry, and both matter when a pregnancy is planned. This is a decision to make with the prescribing doctor before you start trying, not one to make alone by stopping a medicine.

  • The combined pill. Pills containing drospirenone may improve PMS symptoms modestly, on low-quality evidence from five trials and 858 women, with more side effects than placebo (Cochrane 2023). The pill works by stopping ovulation, so it cannot be used while trying. Stopping it does not harm fertility: 83.1% of 14,884 women in 22 studies were pregnant within a year of stopping contraception, however long they had used it (Girum and Wasie 2018).
  • SSRI antidepressants. These are the best-evidenced drug treatment: Cochrane 2024 (34 trials) found they probably reduce symptoms, more when taken every day than only in the second half of the cycle. They also raised the odds of reduced libido or sexual difficulty about two-fold, which is worth knowing when timing sex matters. Second-half-of-cycle dosing falls after ovulation, when an early pregnancy may already have begun. NICE CG192 asks doctors to discuss pregnancy plans with any woman on treatment for a mental health condition, and to weigh what is known about each drug's reproductive safety, the uncertainty over whether reported risks are caused by the drugs themselves, and the risk of discontinuation symptoms, which NICE singles out for paroxetine and venlafaxine.
  • Progesterone. Although still prescribed for it, progesterone has not been shown to treat PMS. There is no evidence that PMS is caused by progesterone deficiency, and luteal-phase progesterone trials were unsuccessful (Yonkers 2008). It should not be taken for PMS in the belief that it will also help fertility.
  • Non-drug options. Cognitive behavioural therapy and exercise are listed as options in a 2025 American Family Physician review, and calcium may help (Yonkers 2008). Vitex agnus-castus (chasteberry) has some evidence for PMS and is claimed to act on prolactin; none of the sources behind this page addresses its safety while trying to conceive, so tell your doctor before taking it.
Stopping the pill and getting pregnant83.1%of 14,884 women in 22 studies were pregnant within 12 months of stopping contraception (95% CI 78.2 to 88.0%); the type of hormonal method and how long the pill had been used did not change the rate.Girum and Wasie, Contraception and Reproductive Medicine 2018;3:9, systematic review and meta-analysis (PMID 30062044; 2023 correction is grammatical only).

What happens next

If your symptoms fit the PMS pattern and you are under a year of trying (six months from 35), the evidence does not support treating PMS as a fertility problem. Chart two cycles if you want a diagnosis, and treat PMS for its own sake if it is disrupting your life.

If the pattern does not fit, or you are past those time limits, ask for a basic fertility workup for both partners rather than PMS treatment. Living with symptoms every month while also waiting for a positive test is genuinely draining, and it is reasonable to want both addressed at the same appointment.

What changed on this page

An earlier version of this article said that hormonal imbalances behind PMS may contribute to fertility problems, that managing PMS can improve fertility outcomes, and that progesterone therapy is a PMS treatment. It also described a journal study and an ASRM review that we could not find. None of these is supported by the sources now cited, and they have been removed or corrected.

Want your results explained?

IVY can read your reports alongside your history and set out what the evidence supports for your situation, and what it does not.

Keep reading

14 Sources

  1. Yonkers KA, O'Brien PMS, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200-10. PMC author manuscript PMC3118460. The Lancet (PubMed Central)
  2. Miller C, Carlson K. Premenstrual Disorders. StatPearls, updated Jan 2026 (NBK532307; PMID 30335340). DSM-5 PMDD criteria; 5-8% moderate to severe. StatPearls Publishing / NCBI Bookshelf
  3. Dutta A, Sharma A. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in India: a systematic review and meta-analysis. Health Promot Perspect. 2021;11(2):161-70. Health Promotion Perspectives (PubMed)
  4. Reilly TJ, et al. The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis. J Affect Disord. 2024;349:534-40. Journal of Affective Disorders (PubMed)
  5. Jespersen C, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database Syst Rev. 2024;8:CD001396. Cochrane (PubMed)
  6. Ma S, Song SJ. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2023;6:CD006586. Cochrane (PubMed)
  7. Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reprod Med. 2018;3:9. Contraception and Reproductive Medicine (PubMed)
  8. Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-79. Recommendation 1.1.1. Human Reproduction (PubMed Central)
  9. ASRM Practice Committee. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021. American Society for Reproductive Medicine
  10. NICE NG257. Fertility problems: assessment and treatment, recommendations 1.16.5 and 1.16.8. 2026. National Institute for Health and Care Excellence
  11. NICE NG73. Endometriosis: diagnosis and management, recommendation 1.3.1. National Institute for Health and Care Excellence
  12. NICE CG192. Antenatal and postnatal mental health, recommendations 1.2.1, 1.4.14 and 1.4.16. National Institute for Health and Care Excellence
  13. Biggs WS, et al. Premenstrual syndrome and premenstrual dysphoric disorder: common questions and answers. Am Fam Physician. 2025;111(4):345-50. American Family Physician (PubMed)
  14. World Health Organization. Infertility fact sheet, 28 November 2025. World Health Organization

Frequently asked questions

Questions this page has not already answered.

Can PMDD cause infertility?

No retrieved evidence shows that PMDD causes infertility. Like PMS, it is triggered by the normal hormone changes of an ovulatory cycle. What PMDD does affect is treatment choice when trying to conceive, because its main treatments are SSRIs and ovulation-suppressing hormones.

Should I get a hormone blood test to diagnose PMS?

Hormone tests do not diagnose PMS, because oestrogen and progesterone levels are normal in women with PMS (Yonkers 2008). Diagnosis rests on the timing of symptoms, ideally recorded daily over two cycles. Blood tests are useful when another cause is suspected, such as thyroid disease or irregular ovulation.

Could my premenstrual symptoms actually be early pregnancy?

Symptoms cannot reliably tell them apart, and nothing in the sources behind this page suggests they can. A urine pregnancy test after a missed period is the reliable way to know.

Does PMS get better or worse after stopping the pill to conceive?

It can return. The pill relieves PMS mainly by stopping the hormone swings of ovulation (Yonkers 2008), so once ovulatory cycles resume, the pattern you had before the pill may come back. That return is not, in itself, a fertility problem.